All
Research
Education
Исследования
Образование
Business
Решения
RU
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Войдите в систему
Department of Cellular Therapy,
Department of Oncology,
Department of Cellular Therapy, Department of Oncology
Else-Marit Inderberg has not added Biography.
If you are Else-Marit Inderberg and would like to personalize this page please email our Author Liaison for assistance.
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.
Cancer immunology, immunotherapy : CII Jul, 2017 | Pubmed ID: 28391357
A TCR-based Chimeric Antigen Receptor.
Scientific reports Sep, 2017 | Pubmed ID: 28878363
Human c-SRC kinase (CSK) overexpression makes T cells dummy.
Cancer immunology, immunotherapy : CII Apr, 2018 | Pubmed ID: 29248956
Artesunate shows potent anti-tumor activity in B-cell lymphoma.
Journal of hematology & oncology Feb, 2018 | Pubmed ID: 29458389
Oslo University Hospital-Radiumhospitalet
Pierre Dillard1,
Hakan Köksal1,
Else-Marit Inderberg1,
Sebastien Wälchli1
1Department of Cellular Therapy, Department of Oncology, Oslo University Hospital-Radiumhospitalet
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены